Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 2,152,160	$ 1,274,669
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in trust account	(2,794,771)	(1,295,815)
Unrealized gain on marketable securities held in trust account	(155,897)	(377,666)
Amortization	100,933	117,817
Net changes in operating assets & liabilities:
Deferred offering costs		236,522
Prepaid expenses	(63,125)	(157,500)
Due to Sponsor	375,834
Accrued offering costs		(31,550)
Accrued expenses	151,542	145,938
Net cash used in operating activities	(233,324)	(87,585)
Cash flows from investing activities:
Investment of cash in trust account	(2,117,731)	(115,000,000)
Cash withdrawn from trust account to redeem public shares	86,382,792
Net cash provided by (used in) investing activities	84,265,061	(115,000,000)
Cash flows from financing activities:
Redemption of public shares	(86,382,792)
Proceeds from Sponsor loan	2,172,403
Proceeds from sale of private placement units		3,300,000
Proceeds from sale of units		114,700,000
Payment of offering costs		(2,829,741)
Net cash (used in) provided by financing activities	(84,210,389)	115,170,259
Net increase (decrease) in cash and cash equivalents	(178,652)	82,674
Cash and cash equivalents at beginning of period	178,652	95,978
Cash and cash equivalents at end of period		178,652
Supplemental disclosure of non-cash investing and financing Activities:
Deferred underwriting compensation		2,875,000
Initial Ordinary share subject to possible redemption		101,200,000
Reclassification of offering costs related to public shares		(5,020,172)
Change in value of ordinary costs related to public shares		18,820,172
Subsequent measurement of ordinary shares subject to redemption (interest earned and unrealized gain on trust account)	$ 5,118,399	$ 1,673,481